PharmaRoth Labs, Inc. announced that it has entered into a definitive agreement with Marcas De Renombre, S.A. De C.V.granting Marcas exclusive rights for the commercialization and distribution of Sucanon(R) in Mexico. The agreement is for 50 years with annual sales increases conditional for continuance of exclusivity, with the first shipment anticipated in June.